China Diagnostic Reagent Industry Report, 2012-2014

86pages

Published Date: January 2013

Published By: Research In China

Category: Pharmaceutical
Description


Chinas diagnostic reagent industry has formed a certain market scale and basis, and is marching from the introduction stage to the growth stage. With the continuous growth in Chinas medical care investment and per capita health care spending, the Chinas diagnostic reagent market has a promising prospect. 

In vitro diagnostic reagents account for more than 90.0% of the output of Chinas diagnostic reagent industry. In 2011, the market scale of in vitro diagnostic reagents reached about RMB 11.4 billion in China, the industry will maintain a growth rate of 15%-20% in the future, and the market scale will hit RMB 20.8 billion in 2015. 

At present, there are only a few integrated in vitro diagnostic reagent enterprises with strong strength in Chinas diagnostic reagent market, including KHB and Fosun Pharma; other enterprises such as Da An Gene, BioSino, Leadman and Livzon have competitive advantages in specific fields such as biochemical diagnosis, immunodiagnosis, and molecular diagnosis. Meanwhile, Chinas in vitro diagnostic reagent industry concentration is low. Among 300-400 enterprises, there are only about 20 enterprises with annual sales of more than RMB 100 million. The enterprises are generally small and have a few product varieties. In 2011, KHB, Da An Gene, BioSino, Leadman only occupied 3.8%, 2.3%, 1.9%, 1.6% of the market respectively. 

As a high-tech industry, the profitability of the overall Chinese diagnostic reagent industry is high. In 2011, among major Chinese diagnostic reagent enterprises, KHB, Da An Gene, BioSino, Kinghawk, Livzon, Leadman all achieved a gross margin of more than 50%; Fosun Pharma reached a gross margin of 40.4%, since diagnostic reagent and instrument business accounts for a lower proportion of its revenue. With the improvement of industry concentration, its expected that the advantageous enterprises with strong capability of technological innovation and large production scale will obtain higher market share and profitability. 

China Diagnostic Reagent Industry Report, 2012-2014 mainly includes the following contents:

  • Market scale, market structure, import and export, competitive landscape, profitability, entry barriers of Chinas diagnostic reagent industry;
  • Regulatory system and policy, industry policy, industrial chain, upstream and downstream of Chinas diagnostic reagent industry; 
  • Development forecast of Chinas diagnostic reagent industry, including the forecast of market scale, major market segments, industry competition, and enterprise development trends;
  • Production, operation, investment, M&A, diagnostic reagent business and development prospect of 15 Chinese diagnostic reagent enterprises.

 

 

Table of Content

1. Overview of Diagnostic Reagent Industry
1.1 Definition
1.2 Classification

2. China Diagnostic Reagent Industry

2.1 Overview
2.2 Market Structure
2.3 Import and Export
2.3.1 Import
2.3.2 Export
2.4 Competitive Landscape
2.4.1 Biochemical Diagnostic Reagents
2.4.2 Immune Diagnostic Reagents
2.4.3 Molecular Diagnostic Reagents
2.4.4 Integrated In Vitro Diagnostic Reagents
2.5 Profitability
2.6 Entry Barriers
2.6.1 Technical Barriers
2.6.2 Quality and Brand Barriers
2.6.3 Marketing Channel Barriers
2.6.4 Market Access Barriers

3. Development Environment of China Diagnostic Reagent Industry
3.1 Policy Environment
3.1.1 Regulatory Policy
3.1.2 Industry Policy
3.2 Upstream and Downstream Industries
3.2.1 Industrial Chain
3.2.2 Upstream
3.2.3 Downstream

4. Development Forecast of China Diagnostic Reagent Industry
4.1 Overall Forecast
4.1.1 Market Demand Drivers
4.1.2 Market Scale Forecast
4.2 Development Trends of Diagnostic Reagent Industry
4.2.1 Biochemical Diagnosis and Immunodiagnosis Will Still Be the Mainstream
4.2.2 Industry Concentration Will Increase
4.2.3 Enterprises with Complete Product Line Integrating Reagents and Instruments will Win

5. Major Chinese Diagnostic Reagent Enterprises

5.1 Shanghai Kehua Bio-engineering Co., Ltd. (KHB)
5.1.1 Profile
5.1.2 Operation
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 R & D and Investment
5.1.6 Customers
5.1.7 Diagnostic Reagent Business
5.1.8 Forecast and Prospect
5.2 Da An Gene Co., Ltd.
5.2.1 Profile
5.2.2 Operation
5.2.3 Revenue Structure
5.2.4 Gross Margin
5.2.5 R & D and Investment
5.2.6 Diagnostic Reagent Business
5.2.7 Forecast and Prospect
5.3 Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
5.3.1 Profile
5.3.2 Operation
5.3.3 Revenue Structure
5.3.4 Gross Margin
5.3.5 R & D and Investment
5.3.6 Diagnostic Reagent Business
5.3.7 Forecast and Prospect
5.4 BioSino Bio-technology and Science Inc.
5.4.1 Profile
5.4.2 Operation
5.4.3 Revenue Structure
5.4.4 R & D and Investment
5.4.5 Forecast and Prospect
5.5 Beijing Kinghawk Pharmaceutical Co., Ltd.
5.5.1 Profile
5.5.2 Operation
5.5.3 Revenue Structure
5.5.4 Gross Margin
5.5.5 Diagnostic Reagent Business
5.5.6 Forecast and Prospect
5.6 Livzon Pharmaceutical Group Inc.
5.6.1 Profile
5.6.2 Operation
5.6.3 Revenue Structure
5.6.4 Gross Margin
5.6.5 Diagnostic Reagent Business
5.6.6 Forecast and Prospect
5.7 Beijing Leadman Biochemistry Co., Ltd.
5.7.1 Profile
5.7.2 Operation
5.7.3 Revenue Structure
5.7.4 Gross Margin
5.7.5 R & D and Investment
5.7.6 Customers
5.7.7 Diagnostic Reagent Business
5.7.8 Forecast and Prospect
5.8 Acon Biotech (Hangzhou) Co., Ltd.
5.8.1 Profile
5.8.2 Operation
5.8.3 Development
5.9 Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
5.9.1 Profile
5.9.2 Operation
5.9.3 Development
5.10 Shanghai Rongsheng Biotech Co., Ltd. (Rsbio)
5.10.1 Profile
5.10.2 Operation
5.10.3 Development
5.11 Shenzhen PG Biotech Co., Ltd.
5.11.1 Profile
5.11.2 Operation
5.12 Shanghai Upper Bio-Tech Pharma Co., Ltd.
5.12.1 Profile
5.12.2 Operation
5.12.3 Development
5.13 Inverness Medical (Shanghai) Co., Ltd.
5.13.1 Profile
5.13.2 Operation
5.14 Blue Cross Bio-Medical (Beijing) Co., Ltd.
5.14.1 Profile
5.14.2 Operation
5.14.3 Development
5.15 Beijing North Institute of Biological Technology (BNIBT)
5.15.1 Profile
5.15.2 Operation
5.15.3 Development


List Of Figures

NA


List Of Tables

NA

More Reports in





» China Human Vaccine Industry Report, 2014-2017

Vaccines can prevent and control infectious diseases, so the demand for these biological products is relatively rigid. In 2013, China’s human vaccine lot release volume grew by 4.9% from a year earlier, and the market size expanded 2.8% year on year. As vaccination is suspected of causing death and some companies (such as Shenzhen Kangtai...


» China Electronic Fuel Injection System Report, 2014-2017

The evolution of automotive electronic technologies and the growing strict requirements on vehicle’s environmental friendiliness has conduced to the electronic control of fuel injection of automobiles in China. It is expected that, in the forthcoming years, Chinese automotive electronic injection industry will keep a steady growth rate of...


» Global and China High Barrier Material (PVDC, EVOH, PEN) Industry Report, 2014-2017

High barrier materials can block the penetration of small molecular gas (such as O2, CO2, N2, water vapor), aroma and other organic solvent vapor prominently. By virtue of better barrier performance, polyvinylidene chloride (PVDC), ethylene / vinyl alcohol copolymer (EVOH) and polyethylene naphthalate (PEN) are mainly used to produce thin films...


» China Styrene Industry Chain Report, 2014-2017

Styrene is an important monomer of a polymer. Global styrene capacity totaled 33.10 million tons in 2013, mainly distributed in Northeast Asia, North America and Western Europe. China boasts the largest styrene capacity with a share of 21.4% in the world. Styrene is used predominately in the production of expanded polystyrene (EPS), gen...


» China Childrens Wear Industry Report, 2014

Since 2013, China children's wear industry has developed with the following characteristics: First, the children's wear market segments have continued to grow rapidly; Despite the sluggish apparel industry, China children's wear industry has bucked the trend and maintained growth. In 2013, the Chinese children's wear market si...


» China Plastic Pipe Industry Report, 2014-2017

China has become the world's largest producer and consumer of plastic pipes. In 2013, China’s plastic pipe output and demand reached 12.1 million tons and 11.117 million tons respectively, representing the respective year-on-year increase of 10.0% and 7.1%. The output of PVC pipes is higher than that of other plastic pipe varieties in Chi...


» China Low-speed Electric Vehicle Industry Report, 2014-2017

Low-speed electric vehicle (LSEV) embraces two-wheeled electric vehicle (electric bicycle, electric motorcycle, etc.), three-wheeled electric vehicle and four-wheeled electric vehicle (all-terrain vehicle, low-speed electric vehicle, etc.). In 2013, China produced 25.29 million two-wheeled electric vehicles, 4.72 million three-wheeled electric ...


» China Orthopedic Instrument Industry Report, 2014-2017

Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale presenting a CAGR of 19.2% during 2009-2013. Trauma products, spine products and joint products are three product segments of orthopedic instrumen...


» Global and China Needle Coke Industry Report, 2014-2016

The global needle coke capacity rose from 920 kt/a to 1,160 kt/a in 2006-2013, registering a CAGR of 3.9%. So far, American and Japanese companies have mastered the needle coke production worldwide. ConocoPhillips as the world’s largest producer of oil-based needle coke saw its capacity up to 370 kt/a in 2013; C-Chem, the largest coal-bas...


» China Electric Vehicle Industry Report, 2014

With the implementation of fiscal subsidies, demonstration and popularization, purchase tax exemption, local barriers-dismantling and other favorable policies, China’s electric vehicle market has seen accelerated development. In the first half of 2014, China’s electric vehicle sales volume exceeded 20,000, more than the last year&rs...



Related News

News Aug 10, 2012

Theranostics Imaging Offers Means of Killing Prostate Cancer Cells without Harming Other Healthy Cells

Cancer imaging experts at John Hopkins Cancer Research Center claimed that they have developed a method for finding and killing malignant cells and sparing the healthy ones. The study was conducted on human prostate cancer cells and mice. The met...

News Oct 29, 2012

The Pharmaceutical Industry And Research

In a world in economic crisis, perhaps still unpredictable consequences in terms of its magnitude and duration, we can reflect on the possible consequences of the crisis may have on the pharmaceutical industry, especially its research and develop...

News Oct 9, 2012

A Donation fund for Pharmaceutical Research

The World Health Organization is planning a Kyoto Protocol for health. States should pay research funds to fight neglected diseases worldwide. To lofty goals lacks the World Health Organization (WHO) does not: It plans with the interests ...

News Oct 10, 2012

Allergy to Cold - Symptoms, Treatment and Tips for Everyday Life

Normally enough warm clothing to defy low outdoor temperatures. Who but suffers from an allergy to cold, has much bigger problems to deal with than "just" cold hands and feet. What is an allergy to cold and how it expresses itself ? ...

News Oct 10, 2012

Healthy Grilling Pleasure

More and more people flock to the park to enjoy the sun. And the barbecue season begins slowly: Instead of greasy sausages and potato salad with mayonnaise, we give you tips for calorie conscious and healthy grilling pleasure. Tonigh...

News Oct 10, 2012

Relaxation on Holiday - but how?

Can the earned annual leave to compensate for the hard work of the rest of the year? We need regular timeouts for regeneration? The recreation research has revealed new aspects. Secured is more important than a good holiday exchange of tension an...

News Oct 10, 2012

Stress and stress that: 7.Stress and Burnout

Everyone knows states of exhaustion - if we have spent ourselves, physically sleep after a long run or mentally after an examination or a combination of both, for example, after a long day at work or when the kids are finally in bed at night...

News Oct 10, 2012

Top 10 Tips for Losing Weight

We summarize now the top 10 tips for losing weight together: They are simple and feasible for anyone who wants to lose weight healthy. A tip from the start: Sets not all weight loss tips to and steps at once, otherwise it will be too much at once...

News Oct 10, 2012

What to do about Anorexia at the Age?

Many people who care for your children at home, the problem: In old age, many people to anorexia. To overcome this, you can use various tricks. First, it helps the members with recipes that they delight to know from your childhood. Especially wit...


All Rights Reserved   Latest News   Latest Reports